Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this extension study is to determine if leuprolide acetate (11.25 mg and 30
mg) is safe in treating children with Central Precocious Puberty over a longer period of time
(36 months).